Tuesday, April 11, 2017 9:52:42 PM
While they acknowledged that it is a common practice to do such a review, they claim they had nothing to do with it getting out and that they have not found anything unscrupulous about CNBX's sudden rise in price.
While I was able to link numerous articles from before CNBX's reply, OTCM said the only article they were involved with was CNBX's reply after the news had broke. ?????
It would seem the good news regarding the trials you linked has not had the impact we would hope.
As people say: CNBX is the same company they were from before February 22nd and have even released more good news since. Let's hope CNBX can start trading back at the higher numbers again based on there not being an issue with their sudden rise in price.
Take care, Jim
Recent CNBX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:27:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 03:13:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/14/2023 02:28:11 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM